Pathophysiology of bacterial meningitis: Summary of the workshop

M. A. Sande, M. G. Tauber, W. M. Scheld, G. H. McCracken

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Many aspects of the pathophysiology of bacterial meningitis have been clarified in recent years. Based on this improved understanding, rational therapeutic approaches that supplement antibiotic treatment can not be logically develolped. Interventions can be directed against harmful bacterial products (e.g. antibodies, polymyxin B), against cytokines (e.g. antibodies, steroids), against WBC (e.g. antibodies, pentoxiphylline) or against some of the pathophysiologic consequences of the disease, such as brain edema, intracranial pressure or alterations of cerebral blood flow. These therapeutic modalities should be tested carefully in animal models and if they prove to be of value they should be evaluated in clinical trials.

Original languageEnglish (US)
Pages (from-to)929-933
Number of pages5
JournalPediatric Infectious Disease Journal
Volume8
Issue number12
StatePublished - 1989

Fingerprint

Bacterial Meningitides
Education
Antibodies
Cerebrovascular Circulation
Polymyxin B
Brain Edema
Intracranial Pressure
Animal Models
Steroids
Clinical Trials
Cytokines
Anti-Bacterial Agents
Therapeutics

Keywords

  • meningitis
  • pathophysiology

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Pathophysiology of bacterial meningitis : Summary of the workshop. / Sande, M. A.; Tauber, M. G.; Scheld, W. M.; McCracken, G. H.

In: Pediatric Infectious Disease Journal, Vol. 8, No. 12, 1989, p. 929-933.

Research output: Contribution to journalArticle

Sande, M. A. ; Tauber, M. G. ; Scheld, W. M. ; McCracken, G. H. / Pathophysiology of bacterial meningitis : Summary of the workshop. In: Pediatric Infectious Disease Journal. 1989 ; Vol. 8, No. 12. pp. 929-933.
@article{d95dcd3258104d1ca6b03e6a6f451a9f,
title = "Pathophysiology of bacterial meningitis: Summary of the workshop",
abstract = "Many aspects of the pathophysiology of bacterial meningitis have been clarified in recent years. Based on this improved understanding, rational therapeutic approaches that supplement antibiotic treatment can not be logically develolped. Interventions can be directed against harmful bacterial products (e.g. antibodies, polymyxin B), against cytokines (e.g. antibodies, steroids), against WBC (e.g. antibodies, pentoxiphylline) or against some of the pathophysiologic consequences of the disease, such as brain edema, intracranial pressure or alterations of cerebral blood flow. These therapeutic modalities should be tested carefully in animal models and if they prove to be of value they should be evaluated in clinical trials.",
keywords = "meningitis, pathophysiology",
author = "Sande, {M. A.} and Tauber, {M. G.} and Scheld, {W. M.} and McCracken, {G. H.}",
year = "1989",
language = "English (US)",
volume = "8",
pages = "929--933",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Pathophysiology of bacterial meningitis

T2 - Summary of the workshop

AU - Sande, M. A.

AU - Tauber, M. G.

AU - Scheld, W. M.

AU - McCracken, G. H.

PY - 1989

Y1 - 1989

N2 - Many aspects of the pathophysiology of bacterial meningitis have been clarified in recent years. Based on this improved understanding, rational therapeutic approaches that supplement antibiotic treatment can not be logically develolped. Interventions can be directed against harmful bacterial products (e.g. antibodies, polymyxin B), against cytokines (e.g. antibodies, steroids), against WBC (e.g. antibodies, pentoxiphylline) or against some of the pathophysiologic consequences of the disease, such as brain edema, intracranial pressure or alterations of cerebral blood flow. These therapeutic modalities should be tested carefully in animal models and if they prove to be of value they should be evaluated in clinical trials.

AB - Many aspects of the pathophysiology of bacterial meningitis have been clarified in recent years. Based on this improved understanding, rational therapeutic approaches that supplement antibiotic treatment can not be logically develolped. Interventions can be directed against harmful bacterial products (e.g. antibodies, polymyxin B), against cytokines (e.g. antibodies, steroids), against WBC (e.g. antibodies, pentoxiphylline) or against some of the pathophysiologic consequences of the disease, such as brain edema, intracranial pressure or alterations of cerebral blood flow. These therapeutic modalities should be tested carefully in animal models and if they prove to be of value they should be evaluated in clinical trials.

KW - meningitis

KW - pathophysiology

UR - http://www.scopus.com/inward/record.url?scp=0024816604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024816604&partnerID=8YFLogxK

M3 - Article

C2 - 2626306

AN - SCOPUS:0024816604

VL - 8

SP - 929

EP - 933

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 12

ER -